133 related articles for article (PubMed ID: 35090829)
1. Limiting Screening Mammography Recalls for Vaccine-Induced Adenopathy, a Single Institution Experience.
Maimone S; Robinson KA; Advani PP; Li Z; Gococo-Benore DA; Qosja N; Ashai AM; Mummareddy A; Chumsri S
Acad Radiol; 2022 Oct; 29(10):1480-1485. PubMed ID: 35090829
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram.
Raj S; Ogola G; Han J
Acad Radiol; 2022 Apr; 29(4):501-507. PubMed ID: 34906409
[TBL] [Abstract][Full Text] [Related]
3. Mitigating the Impact of Coronavirus Disease (COVID-19) Vaccinations on Patients Undergoing Breast Imaging Examinations: A Pragmatic Approach.
Lehman CD; Lamb LR; D'Alessandro HA
AJR Am J Roentgenol; 2021 Sep; 217(3):584-586. PubMed ID: 33617288
[TBL] [Abstract][Full Text] [Related]
4. Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination.
Horvat JV; Sevilimedu V; Becker AS; Perez-Johnston R; Yeh R; Feigin KN
Eur Radiol; 2022 Aug; 32(8):5752-5758. PubMed ID: 35247087
[TBL] [Abstract][Full Text] [Related]
5. Axillary Lymphadenopathy After a COVID-19 Vaccine Booster Dose: Time to Resolution on Ultrasound Follow-Up and Associated Factors.
Mema E; Lane EG; Drotman MB; Eisen CS; Thomas C; Prince MR; Dodelzon K
AJR Am J Roentgenol; 2023 Aug; 221(2):175-183. PubMed ID: 36883774
[No Abstract] [Full Text] [Related]
6. Ultrasound Features to Differentiate COVID-19 Vaccine-Induced Benign Adenopathy from Breast Cancer Related Malignant Adenopathy.
Hl C; Gj W; Jwt L; J S; Lp M; Ht LP
Acad Radiol; 2022 Jul; 29(7):1004-1012. PubMed ID: 35296413
[TBL] [Abstract][Full Text] [Related]
7. Unilateral axillary adenopathy in the setting of COVID-19 vaccine: Follow-up.
Mehta N; Sales RM; Babagbemi K; Levy AD; McGrath AL; Drotman M; Dodelzon K
Clin Imaging; 2021 Dec; 80():83-87. PubMed ID: 34298342
[TBL] [Abstract][Full Text] [Related]
8. Time for Resolution of COVID-19 Vaccine-Related Axillary Lymphadenopathy and Associated Factors.
Lane EG; Eisen CS; Drotman MB; Dodelzon K; Mema E; Thomas C; Prince MR
AJR Am J Roentgenol; 2022 Oct; 219(4):559-568. PubMed ID: 35583425
[No Abstract] [Full Text] [Related]
9. Axillary adenopathy following COVID-19 vaccination: A single institution case series.
Duke H; Posch L; Green L
Clin Imaging; 2021 Dec; 80():111-116. PubMed ID: 34303188
[TBL] [Abstract][Full Text] [Related]
10. Axillary adenopathy detected on breast MRI following COVID-19 vaccination: outcomes and follow-up recommendations.
Nguyen DL; Chen X; Kwak L; Oluyemi ET; Mullen LA; Ambinder EB
Clin Imaging; 2023 Jan; 93():1-3. PubMed ID: 36335676
[TBL] [Abstract][Full Text] [Related]
11. Unilateral axillary Adenopathy in the setting of COVID-19 vaccine.
Mehta N; Sales RM; Babagbemi K; Levy AD; McGrath AL; Drotman M; Dodelzon K
Clin Imaging; 2021 Jul; 75():12-15. PubMed ID: 33486146
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Vaccine-Related Axillary Adenopathy on Breast Imaging: Follow-Up Recommendations and Histopathologic Findings.
Nguyen DL; Ambinder EB; Myers KS; Mullen LA; Panigrahi B; Oluyemi E
AJR Am J Roentgenol; 2022 Jun; 218(6):997-998. PubMed ID: 34935404
[TBL] [Abstract][Full Text] [Related]
13. Axillary Adenopathy after COVID-19 Vaccine: No Reason to Delay Screening Mammogram.
Wolfson S; Kim E; Plaunova A; Bukhman R; Sarmiento RD; Samreen N; Awal D; Sheth MM; Toth HB; Moy L; Reig B
Radiology; 2022 May; 303(2):297-299. PubMed ID: 35133198
[No Abstract] [Full Text] [Related]
14. COVID-19 Vaccine-Related Axillary and Cervical Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CT.
Lane DL; Neelapu SS; Xu G; Weaver O
Korean J Radiol; 2021 Dec; 22(12):1938-1945. PubMed ID: 34719892
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Vaccination-Associated Axillary Adenopathy: Imaging Findings and Follow-Up Recommendations in 23 Women.
Mortazavi S
AJR Am J Roentgenol; 2021 Oct; 217(4):857-858. PubMed ID: 33624520
[TBL] [Abstract][Full Text] [Related]
16. Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care.
Garreffa E; Hamad A; O'Sullivan CC; Hazim AZ; York J; Puri S; Turnbull A; Robertson JF; Goetz MP
Eur J Cancer; 2021 Dec; 159():38-51. PubMed ID: 34731748
[TBL] [Abstract][Full Text] [Related]
17. Analysis of clinical factors and ultrasound features associated with COVID-19 vaccine-related axillary lymphadenopathy: A large group study.
Lim J; Khil EK; Lee SA; Choi JA; Lee KY; Jo SW; Lee J
Clin Imaging; 2024 Jan; 105():110046. PubMed ID: 38039749
[TBL] [Abstract][Full Text] [Related]
18. Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation.
Igual-Rouilleault AC; Soriano I; Quan PL; Fernández-Montero A; Elizalde A; Pina L
Eur Radiol; 2022 May; 32(5):3199-3206. PubMed ID: 34655312
[TBL] [Abstract][Full Text] [Related]
19. Incidence, Timing, and Long-Term Outcomes of COVID-19 Vaccine-Related Lymphadenopathy on Screening Mammography.
Lamb LR; Mercaldo SF; Carney A; Leyva A; D'Alessandro HA; Lehman CD
J Am Coll Radiol; 2024 Mar; ():. PubMed ID: 38461917
[TBL] [Abstract][Full Text] [Related]
20. Frequency and characteristics of additionally detected ipsilateral breast lesions following recall at screening mammography.
Lameijer JR; Coolen AM; Nederend J; Voogd AC; Tjan-Heijnen VC; Duijm LE
Breast; 2018 Dec; 42():94-101. PubMed ID: 30216838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]